Oncopeptides will host a Capital Markets Day on December 14th between 8.30-11.00 AM ET in New York. Speakers will include Jakob Lindberg, Chief Executive Officer, other members of management and Professor Paul G Richardson, Dana-Farber Cancer Institute, Clinical Program Leader & Director of Clinical Research, Jerome Lipper Multiple Myeloma Center. The event will also be webcasted.
The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.